Literature DB >> 14999520

Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women.

Masao Fukunaga1, Toshitaka Nakamura, Masataka Shiraki, Tatsuhiko Kuroda, Hiroaki Ohta, Takayuki Hosoi, Hajime Orimo.   

Abstract

Vertebral fractures are the most common complication associated with osteoporosis. The definition of prevalent or incident vertebral fractures is important in epidemiological evaluation and in clinical trials of osteoporosis treatment. There have been few reports regarding the morphometric cutoff criteria for incident fractures in Asians, and only a few reports of their occurrence in Caucasians. The aim of this study was to establish a definition for incident fractures in Japanese women. A total of 279 women, aged 64.8 +/- 9.9 (mean +/- SD) years, were recruited, and repeated thoracolumbar spinal radiographs were performed at a mean of 1.45 +/- 0.44 years after the baseline film. Vertebral fractures were graded from 0 to 3 in both baseline and follow-up films using a semiquantitative assessment by the consensus of three readers. Incident fractures were defined as an increase of grade, except grade 3, and a vertebral body height of less than 12 mm on the baseline film. As morphometric criteria, both absolute height reduction (AHr) and the percent height ratio (PHr) were calculated. Prevalent fractures were observed in 207 vertebrae (6.2%) and 85 cases (30.5%), and incident fractures in 42 vertebrae (1.3%) and 29 cases (10.4%). As morphometric criteria for incident fracture, both a PHr > or =15% and an AHr > or =3 mm or > or =4 mm indicated sensitivity of 49.17% and 50.83% and specificity of 99.92% and 99.90%, respectively. In conclusion, the morphometric criteria of incident fracture combined with a semiquantitative assessment will provide useful information in the study of clinical osteoporosis, especially for international comparisons.

Entities:  

Mesh:

Year:  2004        PMID: 14999520     DOI: 10.1007/s00774-003-0457-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  15 in total

1.  The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group.

Authors:  Masataka Shiraki; Tatsuhiko Kuroda; Toshitaka Nakamura; Masao Fukunaga; Takayuki Hosoi; Hajime Orimo; Kuniyoshi Makino
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  Bone mineral density and estimated height loss based on patients' recalls.

Authors:  A Moayyeri; S Ahmadi-Abhari; A Hossein-nezhad; B Larijani; A Soltani
Journal:  Osteoporos Int       Date:  2006-03-31       Impact factor: 4.507

3.  Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).

Authors:  Shiro Tanaka; Teruhiko Miyazaki; Yukari Uemura; Tatsuhiko Kuroda; Nobuaki Miyakawa; Toshitaka Nakamura; Masao Fukunaga; Yasuo Ohashi; Hiroaki Ohta; Satoshi Mori; Hiroshi Hagino; Takayuki Hosoi; Toshitsugu Sugimoto; Eiji Itoi; Hajime Orimo; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2013-07-05       Impact factor: 2.626

4.  Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).

Authors:  Masataka Shiraki; Tatsuhiko Kuroda; Nobuaki Miyakawa; Naohito Fujinawa; Kazumasa Tanzawa; Akiko Ishizuka; Shiro Tanaka; Yukari Tanaka; Takayuki Hosoi; Eiji Itoi; Shigeto Morimoto; Akira Itabashi; Toshitsugu Sugimoto; Toshihiko Yamashita; Itsuo Gorai; Satoshi Mori; Hideaki Kishimoto; Hideki Mizunuma; Naoto Endo; Yoshiki Nishizawa; Kunio Takaoka; Yasuo Ohashi; Hiroaki Ohta; Masao Fukunaga; Toshitaka Nakamura; Hajime Orimo
Journal:  J Bone Miner Metab       Date:  2010-05-13       Impact factor: 2.626

5.  Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women.

Authors:  S Tanaka; T Kuroda; M Saito; M Shiraki
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

6.  A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients.

Authors:  Toru Yoshioka; Nobukazu Okimoto; Ken Okamoto; Akinori Sakai
Journal:  J Bone Miner Metab       Date:  2012-10-19       Impact factor: 2.626

7.  Prevalent vertebral deformity independently increases incident vertebral fracture risk in middle-aged and elderly Japanese women: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.

Authors:  E Kadowaki; J Tamaki; M Iki; Y Sato; Y Chiba; E Kajita; S Kagamimori; Y Kagawa; H Yoneshima
Journal:  Osteoporos Int       Date:  2009-11-19       Impact factor: 4.507

8.  Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures.

Authors:  Masataka Shiraki; Tatsuhiko Kuroda; Shiro Tanaka; Mitsuru Saito; Masao Fukunaga; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

9.  Serum 25-hydroxyvitamin D below 25 ng/mL is a risk factor for long bone fracture comparable to bone mineral density in Japanese postmenopausal women.

Authors:  Shiro Tanaka; Tatsuhiko Kuroda; Yasushi Yamazaki; Yumiko Shiraki; Noriko Yoshimura; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2013-09-24       Impact factor: 2.626

10.  The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures.

Authors:  Masataka Shiraki; Tomohiko Urano; Tatsuhiko Kuroda; Mitsuru Saito; Shiro Tanaka; Mariko Miyao-Koshizuka; Satoshi Inoue
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.